Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-25177

Xla Wt + hbg1 cMO, Melchert J et al. (2020)

Experiment + Assay: Xla Wt + hbg1 cMO + WE NF37/38 (RNA-Seq (RNA))
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection   hbg1 (Xla)
 NF stage 4 (8-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
RNA-Seq NF stage 37 and 38  
Expression Phenotypes (5):
increased amount cnfn.2.S expression in the embryo
increased amount fcn1.L expression in the embryo
increased amount ghrh.L expression in the embryo
decreased amount oxct1.S expression in the embryo
increased amount pparg.L expression in the embryo
GEO Series: GSE126058: Xenbase, NCBI
Article: XB-ART-56559, PubMed